Procter & Gamble Q4 sales slightly miss estimates
PG•Outlook
- P&G expects FY 2027 all-in and organic sales growth of 1% to 3%
- Company sees FY 2027 diluted EPS growth of 1% to 5% versus FY 2026
- P&G expects FY 2027 core EPS growth of in-line to 3%, range $6.89 to $7.11
Overview
- U.S. consumer goods maker's Q4 sales rose 2%, slightly missing analyst expectations
- Q4 adjusted EPS beat analyst expectations, though fell 3% yr/yr
- Company cited higher SG&A and lower gross margin as weighing on Q4 profit
Key details
| Metric | Beat/Miss | Actual | Consensus Estimate |
|---|---|---|---|
| Q4 Sales | Slight Miss* | $21.2 bln | $21.38 bln (17 Analysts) |
| Q4 Adjusted EPS | Beat | $1.43 | $1.41 (20 Analysts) |
| Q4 EPS | $1.26 |
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Result drivers
- Segment performance - Beauty segment organic sales rose, but Health Care and Baby, Feminine & Family Care segments saw declines, while other segments were largely flat
